Videos

Following his review of available imaging modalities, Brian Helfand, MD, PhD, considers which scans are most appropriate based on patient and disease factors.

A comprehensive review of imaging modalities available to patients with prostate cancer who are suspected of recurrence.

Specialist Brian Helfand, MD, PhD, reviews the case of a 65-year-old man with prostate cancer and shares insight on strategies to monitor for recurrence.

"It may be something that practicing urologists could already start speaking to their patients about," says Siobhan Sutcliffe, PhD, ScM, MHS.

"It wasn't just about the salary number, but what other things are within the contract that could make a huge difference on your practice and your life," says Siobhan M. Hartigan, MD.

“We highlighted that there is building evidence suggesting clinical benefits for lymph node dissection, such as a clear benefit of staging, which allows us to perform better prognostication for patients,” says Suzanne Lange, MD.

"This has the opportunity to really revolutionize the way we treat kidney stone disease via ureteroscopy," says Naeem Bhojani, MD.

“First and foremost is that same-day discharge appears to be safe. There were no failure-to-rescue events within 24 to 48 hours after discharge outside of the hospital,” says Andrew Wood, MD.

"You have to manage and maintain the other parts of yourself that are not answering all those needs from work," says Jennifer M. Taylor, MD, MPH.

"What really surprised us was that 25% of our Botox cohort had previously undergone nerve stimulation, and those patients were less likely to stop Botox," says Katherine L. Woodburn, MD.

“There's a huge potential role for urologists out there for female sexual health,” says Rachel Pope, MD, MPH.

"We used data from this study to see whether having a greater number of flares independently impacted patients’ quality of life as well as their healthcare seeking activity," said Siobhan Sutcliffe, PhD, ScM, MHS.

“We thought anesthesia type would be relevant. But both urologists and patients determined that it actually was not relevant to their decision making,” says John Michael DiBianco, MD.

“It seems like podcasts really are a good way for people to learn about even a complex topic like this,” says Stacy Loeb, MD, MSc.

"The interesting thing that's come out of the research that Dr. Lebares has done is that burnout can be countered by mindfulness," said Jennifer M. Taylor, MD, MPH.

“These are add-on codes that need to be added on to the evaluation and management service that's done on that patient on that day,” says Jonathan Rubenstein, MD.

“In medicine, we're not taught the business of medicine, but the day that you become faculty at an institution or private practice, you learn that it is a business, but yet nowhere in our training are we taught that,” says Michelle Pearlman, MD.

"In many cases, we're now bringing the capabilities of the hospital into a patient's home," says Timothy D. Lyon, MD, FACS.

“There are just a lot of barriers, unfortunately, to speaking freely about women's sexual health,” says Rachel Pope, MD, MPH.

Study participants were randomly assigned to receive 6 months of HT plus local therapy or 6 months of HT alone.

“We aimed to develop a surgical decision aid to help facilitate this decision-making process for patients who are candidates for either shock wave lithotripsy or ureteroscopy with kidney stones,” says John Michael DiBianco, MD.

“Where we really need to see change is talking about what the patient wants, what they're worried about, and what would work best for them,” says Angela Fagerlin, PhD.

“I think this is a nice cluster of podcasts that really go at this from different angles,” says Stacy Loeb, MD, MSc.

"I think that it's important to have a clear understanding and articulation of what the shared goals are," says Mark S. Litwin, MD, MPH.

“Although people will look back and say, how in the world do urology and gastroenterology fit in with each other? They have everything to do with each other because we focus on the foundation,” says Michelle Pearlman, MD.

The phase 2 SALV-ENZA trial explored whether the addition of enzalutamide to salvage radiation therapy could improve outcomes in patients with high-risk, PSA-recurrent prostate cancer after radical prostatectomy.

“Effective January 1, 2023, anyone who performs a laparoscopic simple prostatectomy should be using CPT code 55867 to report that procedure,” says Jonathan Rubenstein, MD.

Combining the approved antibody-drug conjugates with other agents in this space may provide some synergy and allow even more efficacy and disease control, explains Alicia Morgans, MD.

Benjamin Lowentritt, MD, discusses how the phase 3 SPOTLIGHT trial showed the efficacy of the PSMA-PET imaging agent 18F-rhPSMA-7.3 PET across a variety of subgroups in prostate cancer.

“What's more concerning is we're seeing an increase in advanced or late-stage diagnosis, which I've seen in my practice as well,” says Derek J. Lomas, MD, PharmD.